Abstract
On physical examination, the patient did not have severe clinical symptoms, but he presented with myalgia, exanthema, arthralgia, abdominal pain, headache, fatigue, and nausea. Interestingly, both alanine transaminase (ALT) and aspartate transaminase (AST) remained at normal levels during this simultaneous infection, despite it has observed that dengue infection is associated with accelerated progression of liver damage during the acute infection phase. [...]is the case of interleukin-2, which is associated with an increase in ALT and AST levels, and therefore its inhibition could not only participate in the downregulation of the liver enzymes but also regulate the synthesis and release of the tumor necrosis factor-α, producing a less severe clinical course in those patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Public Health, School of Medicine, University of Colima, Colima; Department of Internal Medicine, Regional University Hospital, Ministry of Health, Colima
2 Department of Public Health, School of Medicine, University of Colima; Cancer State Institute, Ministry of Health, Colima
3 Department of Public Health, School of Medicine, University of Colima, Colima
4 Department of Public Health, School of Medicine, University of Colima, Colima, México; Center for Gene Therapy, Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, CA, USA